open access

Vol 15, No 3 (2019)
Review paper
Published online: 2019-06-26
Get Citation

Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers

Krzysztof Warzocha1, Wojciech Homenda2, Andrzej Pluta3, Tomasz Sacha3, Maria Cioch4, Marek Dudziński5, Dorota Krochmalczyk6, Joanna Góra-Tybor1, Ilona Seferyńska1, Monika Joks7, Marta Sobas8
DOI: 10.5603/OCP.2019.0021
·
Oncol Clin Pract 2019;15(3):167-179.
Affiliations
  1. Department of Haematology, Institute of Haematology and Transfusion Medicine, Warszawa, Poland
  2. Department of Physiotherapy and Emergency Medicine, Pomeranian University, Słupsk, Poland
  3. Department of Haematology, Collegium Medicum of Jagiellonian University, Kraków, Poland
  4. Department of Haemato-oncology and Bone Marrow Transplantation, Medical University of Lublin, Poland
  5. Department of Haematology, Clinical Voivodeship Hospital no. 1, Rzeszów, Poland
  6. Clinical Ward of Haematology, University Hospital, Kraków, Poland
  7. Department of Haematology and Steam Cell Transplantation, University of Medical Sciences, Poznań, Poland
  8. Department of Haematology, Blood Neoplasm and Bone Marrows Transplantation, Medical University, Wrocław, Poland

open access

Vol 15, No 3 (2019)
REVIEW ARTICLES
Published online: 2019-06-26

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers

Journal

Oncology in Clinical Practice

Issue

Vol 15, No 3 (2019)

Article type

Review paper

Pages

167-179

Published online

2019-06-26

Page views

784

Article views/downloads

978

DOI

10.5603/OCP.2019.0021

Bibliographic record

Oncol Clin Pract 2019;15(3):167-179.

Authors

Krzysztof Warzocha
Wojciech Homenda
Andrzej Pluta
Tomasz Sacha
Maria Cioch
Marek Dudziński
Dorota Krochmalczyk
Joanna Góra-Tybor
Ilona Seferyńska
Monika Joks
Marta Sobas

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl